Tysabri: "More Patients Are Beginning To Lose Patience With FDA"
"...A couple of recent surveys show that patients want the right to decide for themselves whether to use potentially risky drugs for chronic diseases. In both surveys 90% of respondents said patients, in consultation with their doctors, should be able to choose a prescription drug that might have side effects. Patients don't want the Food and Drug Administration restricting drugs that might benefit them, says John Calfee, an AEI resident scholar and author of its report. 'Once patients know the risks, they really think that the decisions should be made by them and their doctors,' Calfee said.

The AEI survey was paid for by Biogen Idec, (BIIB) which, with Elan, (ELN) partnered to make the MS drug Tysabri....."